Age, years | 50.6 ± 8.4 |
Waist circumference, cm | 113 ± 12 |
Body mass index, kg/m2 | 31.8 ± 4.9 |
Systolic blood pressure, mmHg | 139 ± 14 |
Diastolic blood pressure, mmHg | 82 ± 8 |
Resting heart rate, bpm | 65 ± 10 |
Physical activity, kcal/week | 1066 ± 1370 |
Medication | |
• Aspirin, n (%) | 17 (16%) |
• Beta-blockers, n (%) | 30 (29%) |
• ACE-inhibitors, n (%) | 15 (14%) |
• ARBs, n (%) | 25 (24%) |
• CCBs, n (%) | 3 (3%) |
• Diuretics, n (%) | 18 (17%) |
• Statins, n (%) | 24 (23%) |
• Glucose-lowering drugs, n (%) | 15 (14%) |
Smoking | |
• Current, n (%) | 21 (20%) |
• Former, n (%) | 49 (47%) |
• Never, n (%) | 35 (33%) |
Number of pack-years in smokers | 16 ± 14 |
Fasting glucose, mmol/L | 6.8 ± 1.8 |
HbA1c, mmol/L | 44.5 ± 11.0 |
Total cholesterol, mmol/L | 5.6 ± 1.4 |
HDL-Cholesterol, mmol/L | 1.2 ± 0.3 |
LDL-Cholesterol, mmol/L | 3.4 ± 1.1 |
Triglycerides, mmol/L | 2.9 ± 3.4 |
hs-CRP, mg/L | |
• Optimal (< 1.0 mg/L) | 41 (39%) |
• Not optimal (≥ 1.0 mg/L) | 64 (61%) |
C1, mL/mmHg x 10 | |
• Normal | 93 (90%) |
• Borderline decreased | 10 (10%) |
C2, mL/mmHg x 100 | |
• Normal | 42 (41%) |
• Borderline decreased | 30 (29%) |
• Abnormal | 31 (30%) |
OxLDL, U/L | |
• Low risk (< 60 U/L) | 34 (33%) |
• Moderate risk (≥ 60 and < 70 U/L) | 8 (8%) |
• High risk (≥ 70 U/L) | 60 (59%) |
FINRISK, % | |
• Low risk (< 5%) | 33 (31%) |
• Medium risk (5-14.9%) | 45 (43%) |
• High risk (≥ 15%) | 27 (26%) |
SCORE, % | |
• Low risk (< 3%) | 56 (53%) |
• Medium risk (3-4.9%) | 25 (24%) |
• High risk (≥ 5%) | 24 (23%) |